Buprenorphine for Late-Life Treatment Resistant Depression
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The goals of this pilot study are to gather data about the safety and clinical effect of
low-dose buprenorphine in older adults with treatment resistant depression.
Phase:
Phase 2
Details
Lead Sponsor:
University of Pittsburgh
Collaborators:
National Center for Research Resources (NCRR) National Institutes of Health (NIH) Reckitt Benckiser LLC